Amir Sarayani, PharmD, MPH, PhD

Associate Director
Global Epidemiology, Johnson & Johnson, United States

Disclosure information not submitted.

Presentation(s):

• SC-19 - Risk Minimisation and Communication: Pharmacoepidemiological Approaches and Case Studies for Designing and Evaluating Interventions for the Safe Use of Medicines

  Saturday, August 23, 2025
  9:00 AM - 12:30 PM ET

• 3G-02 - Patterns of Topiramate Use Among Women of Childbearing Potential in the USA (2000-2023)

  Monday, August 25, 2025
  8:30 AM - 8:45 AM ET

• 5D - Disproportionality Proportionate: Pharmacovigilance Methods

  Tuesday, August 26, 2025
  8:30 AM - 10:00 AM ET